Bozitinib
Bozitinib is a highly selective ATP-competitive c-Met inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) selectively inhibits MET-altered tumor cells in preclinical models.
| Trivial name | PLB-1001, CBT-101, APL-101, CBI-3103 |
| Catalog Number | S6762 |
| CAS# | 1440964-89-5 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/bozitinib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/bozitinib-chemical-structure-s6762.gif |